Ibrutinib, Bortezomib and Rituximab-CHOP for the Treatment of Elderly Patients With CD20+ DLBCL, IPI ≥ 2
Clinical trial NCT03129828 · COMPLETED
Trial details
- NCT number
- NCT03129828
- Sponsor
- Prof. Dr. Clemens Schmitt
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-17
- Primary completion
- 2024-11-12
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.